Schubert & Co’s Johnson & Johnson JNJ Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$438K Buy
1,790
+17
+1% +$3.96K 0.36% 45
2025
Q4
$367K Sell
1,773
-285
-14% -$56.4K 0.29% 52
2025
Q3
$382K Sell
2,058
-86
-4% -$14.7K 0.28% 51
2025
Q2
$328K Buy
2,144
+117
+6% +$18K 0.23% 49
2025
Q1
$336K Buy
2,027
+476
+31% +$74.5K 0.23% 44
2024
Q4
$224K Sell
1,551
-66
-4% -$10.2K 0.15% 55
2024
Q3
$262K Buy
1,617
+15
+0.9% +$2.39K 0.19% 50
2024
Q2
$253K Hold
1,602
0.22% 29
2024
Q1
$253K Sell
1,602
-50
-3% -$7.96K 0.22% 29
2023
Q4
$259K Sell
1,652
-392
-19% -$60.1K 0.23% 29
2023
Q3
$318K Sell
2,044
-47
-2% -$7.75K 0.32% 22
2023
Q2
$346K Buy
2,091
+115
+6% +$18.6K 0.32% 20
2023
Q1
$306K Sell
1,976
-485
-20% -$78.3K 0.27% 21
2022
Q4
$435K Sell
2,461
-53
-2% -$9.15K 0.4% 19
2022
Q3
$411K Buy
2,514
+4
+0.2% +$677 0.39% 18
2022
Q2
$446K Buy
2,510
+151
+6% +$26.9K 0.42% 15
2022
Q1
$418K Buy
2,359
+89
+4% +$15.1K 0.46% 12
2021
Q4
$388K Buy
+2,270
New +$372K 0.39% 15

Other funds holding JNJ

Schubert & Co's JNJ Position: Q1 2026 in Review

Schubert & Co increased its Johnson & Johnson (JNJ) stake by 0.96% in Q1 2026, buying an estimated $3.96K and bringing the position to 1,790 shares worth $438K. The position accounts for 0.36% of the portfolio, ranked #45.

Schubert & Co first reported a position in JNJ in Q4 2021 and has held it in 18 quarters since. The position peaked at $446K in Q2 2022. 4,616 funds tracked by Wall St. Rank hold JNJ as of Q1 2026.

  • Schubert & Co held 1,790 shares of Johnson & Johnson worth $438K as of Q1 2026.
  • Schubert & Co bought 17 Johnson & Johnson shares in Q1 2026, an estimated $3.96K.
  • Johnson & Johnson made up 0.36% of Schubert & Co's portfolio in Q1 2026, its #45 holding.
  • Schubert & Co first reported a position in Johnson & Johnson in Q4 2021 and has held it in 18 quarters since.
  • Schubert & Co's Johnson & Johnson position peaked at $446K in Q2 2022.
  • 4,616 funds tracked by Wall St. Rank held Johnson & Johnson as of Q1 2026.

Based on Schubert & Co's 13F filing for Q1 2026, filed 29 Apr 2026.